Blood-Based biomarkers in alzheimer disease: Where are we now and where have we to go?

Archives of Neurology

Volumn 70, Issue 1, 2013, Pages 133-

  Laske, Christoph ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; TAU PROTEIN; PLASMA PROTEIN;

ALZHEIMER DISEASE; BLOOD ANALYSIS; CEREBROSPINAL FLUID; DISEASE CLASSIFICATION; HUMAN; LETTER; MILD COGNITIVE IMPAIRMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; BLOOD; FEMALE; GENE EXPRESSION REGULATION; MALE; METABOLISM; NOTE; PHYSIOLOGY; MENTAL TEST; VALIDATION PROCESS;

ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BLOOD PROTEINS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE;

MLCS; MLOWN;

EID: 84872672129     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/2013.jamaneurol.67     Document Type: Letter

References (4)

1. Doecke JD, Laws SM, Faux NG, et al; for the Alzheimer's Disease Neuroimaging Initiative and Australian Imaging Biomarker and Lifestyle Research Group. Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch Neurol. 2012;69(10):1318-1325.
2. Ray S, Britschgi M, Herbert C, et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med. 2007; 13(11):1359-1362. (Pubitemid 350073592)
3. O'Bryant SE, Xiao G, Barber R, et al; Texas Alzheimer's Research Consortium. A serum protein-based algorithm for the detection of Alzheimer disease. Arch Neurol. 2010;67(9):1077-1081.
4. Laske C, Leyhe T, Stransky E, Hoffmann N, Fallgatter AJ, Dietzsch J. Identification of a blood-based biomarker panel for classification of Alzheimer's disease. Int J Neuropsychopharmacol. 2011;14(9):1147-1155.